Company: GLPG
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001558370-25-003806
Chunk: 473

Company: GALAPAGOS NV
Filing Date: 2025-03-27
Form: 20-F
Item: Item 19
Chunk 473
---
        ​        ​        ​     
Less amount due for settlement within 12 months   ​   ​       3,479   ​      ​      4,652   ​   ​        3,479    ​        ​        4,652 
Amount due for settlement after 12 months         ​   €       8,243   ​      €      4,944   ​   €        8,243    ​        €        4,944 
​
​
We refer to note 15 Property, plant and equipment, for details on the right-of-use assets.

F-52

26. Trade and other liabilities and other non-current liabilities​

                                 ​                                     ​    ​       ​       ​      ​        ​   
----------------------------------------------------------------------------------------------------------------
​                                                                      ​   December 31,                         
​                                                                      2024                2023                 
​                                                                      ​   (Euro, in thousands)                 
Trade and other liabilities                                            ​   €      97,780   ​      €      134,653
Current financial instruments                                          ​   ​           5   ​      ​            —
Accrued charges                                                        ​   ​       1,092   ​      ​          548
Total trade and other liabilities                                      ​   €      98,877   ​      €      135,201
​                                                                      ​   ​           ​   ​      ​            ​
​                                                                      ​   ​           ​   ​      ​            ​
Non-current contingent consideration related to milestones CellPoint   ​   €      20,576   ​      €       20,972
Other non-current liabilities                                          ​   ​      13,245   ​      ​       10,598
Total other non-current liabilities                                    ​   €      33,821   ​      €       31,570
​
​
The carrying value of trade and other liabilities approximates their fair value.The contingent consideration arrangement relating to the acquisition of CellPoint requires us to pay the former owners of CellPoint additional considerations up to €100.0 million. This amount is due when certain sequential development (€20.0 million), regulatory (€30.0 million) and sales-based (€50.0 million) milestones would be achieved. Total fair value at acquisition date of these milestones amounted to €20.2 million at acquisition date.The fair value measurement is based on significant inputs that are not observable in the market, which are classified as Level 3 inputs. Key assumptions in the valuation at